1Sizonenko PC. Effects of inhaled or nasal glucocorticosteroids on adrenal function and growth. J Pediatr Endocrinol Metab, 2002,15: 5-26.
2Lipworth BJ,Jackson CM. Safety of inhaled and intranasal corticosteroids: lessons for the new millennium. Drug Saf, 2000,23: 11-33.
3Allen DB. Systemic effects of intranasal steroids: an endocrinologist's perspective. J Allergy Clin Immunol, 2000, 106(4 Suppl): S179-S190.
4Miller-Larsson A, Mattsson H, Hjertberg E, et al. Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue. Drug Metab Dispos, 1998,26: 623-630.
5Wieslander E, Delander EL, Jarkelid L, et al. Pharmacologic importance of the reversible fatty acid conjugation of budesonide studied in a rat cell line In vitro. Am J Respir Cell Mol Biol, 1998,19: 477-484.
7Scadding GK. Intranasal steroid sprays in the treatment of rhinitis is one better than another? J Laryngol Otol, 2004,118: 395-396.
8Doull IJ, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med, 1995, 151: 1715-1719.
9Clark DJ, Clark RA, Lipworth BJ. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children. Thorax, 1996, 51: 941-943.
10Drake AJ, Howells RJ, Shield JP, et al. Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate. BMJ, 2002,324: 1081-1082.
